0000899243-23-005242.txt : 20230216 0000899243-23-005242.hdr.sgml : 20230216 20230216160517 ACCESSION NUMBER: 0000899243-23-005242 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamdy Ahmed MD CENTRAL INDEX KEY: 0001458506 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39244 FILM NUMBER: 23638529 MAIL ADDRESS: STREET 1: 995 EAST ARQUES AVENUE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vincerx Pharma, Inc. CENTRAL INDEX KEY: 0001796129 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 833197402 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 SHERIDAN AVENUE STREET 2: SUITE 400 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-800-6676 MAIL ADDRESS: STREET 1: 260 SHERIDAN AVENUE STREET 2: SUITE 400 CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Vincera Pharma, Inc. DATE OF NAME CHANGE: 20201223 FORMER COMPANY: FORMER CONFORMED NAME: LifeSci Acquisition Corp. DATE OF NAME CHANGE: 20191206 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-15 0 0001796129 Vincerx Pharma, Inc. VINC 0001458506 Hamdy Ahmed MD 260 SHERIDAN AVENUE, SUITE 400 PALO ALTO CA 94306 1 1 0 0 Chief Executive Officer Stock Option (right to buy) 1.17 2023-02-15 4 A 0 90000 0.00 A 2033-02-14 Common Stock 90000 90000 D Option vests in twenty-four equal monthly installments starting from February 15, 2023. Represents the 3rd tranche of stock option grants previously approved by the Compensation Committee on August 25, 2022. By: /s/ Ahmed M. Hamdy 2023-02-16